Cargando…

A New Specific Succinate-Glutamate Metabolomic Hallmark in Sdhx-Related Paragangliomas

Paragangliomas (PGLs) are frequently associated with germline mutations in genes involved in energy metabolism. The purpose of the present study was to assess whether the tumor metabolomic profile of patients with hereditary and apparently sporadic PGLs enables the distinction of different subtypes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Imperiale, Alessio, Moussallieh, François-Marie, Sebag, Frédéric, Brunaud, Laurent, Barlier, Anne, Elbayed, Karim, Bachellier, Philippe, Goichot, Bernard, Pacak, Karel, Namer, Izzie-Jacques, Taïeb, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842321/ https://www.ncbi.nlm.nih.gov/pubmed/24312232 http://dx.doi.org/10.1371/journal.pone.0080539

Ejemplares similares

Metabolome Profiling by HRMAS NMR Spectroscopy of Pheochromocytomas and Paragangliomas Detects SDH Deficiency: Clinical and Pathophysiological Implications()()
por: Imperiale, Alessio, et al.
Publicado: (2015)

Reactive Oxygen Species: A Promising Therapeutic Target for SDHx-Mutated Pheochromocytoma and Paraganglioma
por: Hadrava Vanova, Katerina, et al.
Publicado: (2021)

Paraganglioma of the organ of Zuckerkandl associated with a somatic HIF2α mutation: A case report
por: Abdullah, Ahmad Esmaeel, et al.
Publicado: (2017)

Towards real-time metabolic profiling of a biopsy specimen during a surgical operation by (1)H high resolution magic angle spinning nuclear magnetic resonance: a case report
por: Piotto, Martial, et al.
Publicado: (2012)

OR29-6 Brown Adipose Tissue Activation in SDHx-Related Pheochromocytoma and Paraganglioma: An Ominous Sign?
por: Abdul Sater, Zahraa, et al.
Publicado: (2019)

THU612 SDHx Pheochromocytoma/Paraganglioma Has Elevation Of Arginine And Lysine Metabolites
por: Ghayee, Hans Kumar, et al.
Publicado: (2023)

Mediastinal paragangliomas related to SDHx gene mutations
por: Michałowska, Ilona, et al.
Publicado: (2016)

Model systems in SDHx-related pheochromocytoma/paraganglioma
por: Takács-Vellai, Krisztina, et al.
Publicado: (2021)

The Emerging Role of Succinate Dehyrogenase Genes (SDHx) in Tumorigenesis
por: Nazar, Elham, et al.
Publicado: (2019)

Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019)

Immunohistochemistry and Mutation Analysis of SDHx Genes in Carotid Paragangliomas
por: Snezhkina, Anastasiya V., et al.
Publicado: (2020)

Pheochromocytoma (PHEO) and Paraganglioma (PGL)
por: Pacak, Karel, et al.
Publicado: (2019)

Using Multimodal Functional Imaging in the Management of SDHx-Related Pheochromocytoma and Paraganglioma
por: White, Gemma, et al.
Publicado: (2021)

Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases
por: Imperiale, Alessio, et al.
Publicado: (2019)

Master regulator analysis of paragangliomas carrying SDHx, VHL, or MAML3 genetic alterations
por: Smestad, John A., et al.
Publicado: (2019)

Tumor Detection Rates in Screening of Individuals with SDHx-related Hereditary Paraganglioma-Pheochromocytoma Syndrome
por: Greenberg, Samantha E., et al.
Publicado: (2020)

A Clinical Efficacy of PRRT in Patients with Advanced, Nonresectable, Paraganglioma-Pheochromocytoma, Related to SDHx Gene Mutation
por: Kolasinska-Ćwikła, Agnieszka, et al.
Publicado: (2019)

Performances of Functional and Anatomic Imaging Modalities in Succinate Dehydrogenase A-Related Metastatic Pheochromocytoma and Paraganglioma
por: Patel, Mayank, et al.
Publicado: (2022)

Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas
por: Matlac, Dieter M., et al.
Publicado: (2021)

FDG-PET/CT findings of atypical (bizarre/symplastic) uterine leiomyoma in a patient with abdominal leiomyosarcoma
por: Hubelé, Fabrice, et al.
Publicado: (2015)

Personalized Management of Pheochromocytoma and Paraganglioma
por: Nölting, Svenja, et al.
Publicado: (2021)

International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers
por: Amar, Laurence, et al.
Publicado: (2021)

Simultaneous Resection of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases: Safety and Oncological Efficacy
por: Addeo, Pietro, et al.
Publicado: (2022)

SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas
por: Armstrong, Neali, et al.
Publicado: (2022)

Somatostatin Receptors and Analogs in Pheochromocytoma and Paraganglioma: Old Players in a New Precision Medicine World
por: Patel, Mayank, et al.
Publicado: (2021)

New insights on the pathogenesis of paraganglioma and pheochromocytoma
por: Kantorovich, Vitaly, et al.
Publicado: (2018)

Metabolomic Characterization of Ovarian Epithelial Carcinomas by HRMAS-NMR Spectroscopy
por: Ben Sellem, D., et al.
Publicado: (2011)

Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies
por: Barbolosi, Dominique, et al.
Publicado: (2018)

Gene Expression Mapping of Histone Deacetylases and Co-factors, and Correlation with Survival Time and (1)H-HRMAS Metabolomic Profile in Human Gliomas
por: Dali-Youcef, Nassim, et al.
Publicado: (2015)

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
por: Crona, Joakim, et al.
Publicado: (2018)

Pheochromocytoma and Paraganglioma: Current Functional and Future Molecular Imaging
por: Blanchet, Elise M., et al.
Publicado: (2012)

(18)F-FDOPA PET/CT Combined with MRI for Gross Tumor Volume Delineation in Patients with Skull Base Paraganglioma
por: Helali, Mehdi, et al.
Publicado: (2019)

Metabolome-guided genomics to identify mutations in isocitrate dehydrogenase, fumarate hydratase and succinate dehydrogenase genes in pheochromocytoma and paraganglioma
por: Richter, Susan, et al.
Publicado: (2018)

Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
por: Ilanchezhian, Maran, et al.
Publicado: (2020)

Pheochromocytomas and Paragangliomas: From Genetic Diversity to Targeted Therapies
por: Pang, Ying, et al.
Publicado: (2019)

Succinate dehydrogenase‐deficient malignant paraganglioma complicated by succinate dehydrogenase‐deficient renal cell carcinoma
por: Yamaguchi, Yoshitomo, et al.
Publicado: (2022)

Succinate Dehydrogenase Loss in Familial Paraganglioma: Biochemistry, Genetics, and Epigenetics
por: Her, Yeng F., et al.
Publicado: (2015)

Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer
por: Ni, Ying, et al.
Publicado: (2015)

Genotype–phenotype associations in PPGLs in 59 patients with variants in SDHX genes
por: Main, Ailsa Maria, et al.
Publicado: (2020)

Postoperative Management in Patients with Pheochromocytoma and Paraganglioma
por: Mamilla, Divya, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gre9v8lfe0u3h7v4fg950mauve